Snowball logo
logo
4884

Kringle Pharma Inc.

4884 TSE
¥411.00¥0.00  (0%)
Estimate
EPS
-130.13
Beta
0.407
Growth
Revenue, YoY
-1.9%
Net income, YoY
-4.98%
About the company
Ticker
4884
ISIN
Country
Japan
Sector (GICS)
Healthcare
Kringle Pharma, Inc. engages in research and develops therapeutic agents for the treatment of intractable diseases in Japan. The company develops HGF products for the treatment of acute spinal cord injury, amyotrophic lateral sclerosis, vocal fold scar, and acute kidney injury. Kringle Pharma, Inc. was incorporated in 2001 and is based in Kita, Japan.

Frequently asked questions

What sector does Kringle Pharma Inc. (4884) operate in?

Kringle Pharma Inc. belongs to the Healthcare sector and operates in the Biotechnology industry.

What is Kringle Pharma Inc. (4884) current stock price?

As of the latest data, Kringle Pharma Inc. stock price is ¥411, with a previous close of ¥411.

What is Kringle Pharma Inc. (4884) current market capitalization?

Kringle Pharma Inc. market cap is approximately 3.32 billion.

What is Kringle Pharma Inc. (4884) Earnings Per Share (EPS)?

The trailing EPS is -¥130.

What is Kringle Pharma Inc. (4884) EBITDA?

Kringle Pharma Inc. EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -315.37 million.

Does Kringle Pharma Inc. (4884) pay dividends?

No. Kringle Pharma Inc. does not pay a dividend.

What is Kringle Pharma Inc. (4884) beta (volatility) score?

Kringle Pharma Inc. has a beta of 0.407, indicating lower volatility than the overall market.